Literature DB >> 23411706

Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy.

Yasuko Ohe1, Takeshi Hayashi, Kazuhiko Mishima, Ryo Nishikawa, Atsushi Sasaki, Hiroshi Matsuda, Akira Uchino, Norio Tanahashi.   

Abstract

A 72-year-old man was admitted with left homonymous hemianopsia and hemiparesis. Magnetic resonance imaging revealed a heterogeneously enhanced lesion in the right parietal lobe. A brain biopsy showed acute demyelination without malignancy, which led to a diagnosis of tumefactive multiple sclerosis (MS). The patient received corticosteroid therapy and experienced clinical and radiological improvement. Six months later, new lesions appeared, and a second biopsy revealed proliferation of dysplastic lymphocytes. This led to a revised diagnosis of primary central nervous system lymphoma (PCNSL). Because PCNSL mimics MS both clinically and radiologically, PCNSL is difficult to diagnose. Performing repeated brain biopsies may therefore be required when PCNSL is strongly suspected.

Entities:  

Mesh:

Year:  2013        PMID: 23411706     DOI: 10.2169/internalmedicine.52.8531

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  10 in total

Review 1.  Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention.

Authors:  Andrew J Solomon; Brian G Weinshenker
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

2.  The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.

Authors:  Tilman Hottenrott; Elisabeth Schorb; Kristina Fritsch; Rick Dersch; Benjamin Berger; Daniela Huzly; Sebastian Rauer; Ludger Tebartz van Elst; Dominique Endres; Oliver Stich
Journal:  J Neurol       Date:  2018-03-06       Impact factor: 4.849

3.  Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.

Authors:  Matthew A Tremblay; Javier E Villanueva-Meyer; Soonmee Cha; Tarik Tihan; Jeffrey M Gelfand
Journal:  J Neurol Sci       Date:  2017-08-10       Impact factor: 3.181

Review 4.  A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis.

Authors:  Michel Toledano; Brian G Weinshenker; Andrew J Solomon
Journal:  Curr Neurol Neurosci Rep       Date:  2015-08       Impact factor: 6.030

5.  Primary Central Nervous System Lymphoma.

Authors:  Yan-Hong Dong; Zhen-Jie Teng; Ming Hu; Ci Wei; Ying-Min Chen; Huan-Fen Zhao; Shu-Qian Zhang; Pei-Yuan Lyu
Journal:  Chin Med J (Engl)       Date:  2016-03-05       Impact factor: 2.628

6.  Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas.

Authors:  Michalina Zajdel; Grzegorz Rymkiewicz; Maria Sromek; Maria Cieslikowska; Pawel Swoboda; Mariusz Kulinczak; Krzysztof Goryca; Zbigniew Bystydzienski; Katarzyna Blachnio; Beata Ostrowska; Anita Borysiuk; Agnieszka Druzd-Sitek; Jan Walewski; Magdalena Chechlinska; Jan Konrad Siwicki
Journal:  Cancers (Basel)       Date:  2019-10-25       Impact factor: 6.639

7.  Vanishing Brain Lesions in a Patient with Vision Loss and Ataxia: A Case of CNS Lymphoma with Corticosteroid Related Regression.

Authors:  Arunmozhimaran Elavarasi; Shilpa Rao; Subasree Ramakrishnan; Dhananjay Bhatt
Journal:  Ann Indian Acad Neurol       Date:  2022-01-13       Impact factor: 1.714

8.  Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma.

Authors:  Chenjing Sun; Jinming Han; Ye Lin; Xiaokun Qi; Changqing Li; Jianguo Liu; Feng Qiu
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

Review 9.  Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring.

Authors:  C Chiavazza; A Pellerino; F Ferrio; A Cistaro; R Soffietti; R Rudà
Journal:  Biomed Res Int       Date:  2018-06-21       Impact factor: 3.411

10.  Histopathological variation in the demyelinating sentinel lesion of primary central nervous system lymphoma.

Authors:  Madan Bajagain; Tatsuki Oyoshi; Tomoko Hanada; Nayuta Higa; Tsubasa Hiraki; Kiyohisa Kamimura; Shinichi Kuroki; Koji Yoshimoto
Journal:  Surg Neurol Int       Date:  2020-10-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.